Search research articles
Contact Us
Filters
Showing results (151-160 of 164) with videos related to
Page
of 17
Sort By:
EMBO Reports
|
May 30, 2024
Targeting ATP2B1 impairs PI3K/Akt/FOXO signaling and reduces SARS-COV-2 infection and replication
Pasqualino de Antonellis, Veronica Ferrucci, Marco Miceli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 23, 2025
Patient-derived neuroblastoma models are sensitive to nucleolin-recognizing liposomal drugs
Veronica Bensa, Hugo Lopes-Cardoso, Eleonora Ciampi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 5, 2022
Germline rare variants of lectin pathway genes predispose to asymptomatic SARS-CoV-2 infection in elderly individuals
Giuseppe D'Alterio, Vito Alessandro Lasorsa, Ferdinando Bonfiglio, et al.
Carcinogenesis
|
October 13, 2019
Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene
Marianna Avitabile, Mariangela Succoio, Alessandro Testori, et al.
Cancer Research
|
February 22, 2012
Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity
Kristopher R Bosse, Sharon J Diskin, Kristina A Cole, et al.
Nature Genetics
|
May 5, 2009
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
Mario Capasso, Marcella Devoto, Cuiping Hou, et al.
The New England Journal of Medicine
|
May 9, 2008
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma
John M Maris, Yael P Mosse, Jonathan P Bradfield, et al.
Nature
|
November 13, 2015
Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
Derek A Oldridge, Andrew C Wood, Nina Weichert-Leahey, et al.
Journal of Translational Medicine
|
February 13, 2024
From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models
Mario Capasso, Chiara Brignole, Vito A Lasorsa, et al.
Viruses
|
June 24, 2022
Carriers of <i>ADAMTS13</i> Rare Variants Are at High Risk of Life-Threatening COVID-19
Kristina Zguro, Margherita Baldassarri, Francesca Fava, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 164) with videos related to
Sort By:
Page
of 17
EMBO Reports
|
May 30, 2024
Targeting ATP2B1 impairs PI3K/Akt/FOXO signaling and reduces SARS-COV-2 infection and replication
Pasqualino de Antonellis, Veronica Ferrucci, Marco Miceli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 23, 2025
Patient-derived neuroblastoma models are sensitive to nucleolin-recognizing liposomal drugs
Veronica Bensa, Hugo Lopes-Cardoso, Eleonora Ciampi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 5, 2022
Germline rare variants of lectin pathway genes predispose to asymptomatic SARS-CoV-2 infection in elderly individuals
Giuseppe D'Alterio, Vito Alessandro Lasorsa, Ferdinando Bonfiglio, et al.
Carcinogenesis
|
October 13, 2019
Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene
Marianna Avitabile, Mariangela Succoio, Alessandro Testori, et al.
Cancer Research
|
February 22, 2012
Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity
Kristopher R Bosse, Sharon J Diskin, Kristina A Cole, et al.
Nature Genetics
|
May 5, 2009
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
Mario Capasso, Marcella Devoto, Cuiping Hou, et al.
The New England Journal of Medicine
|
May 9, 2008
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma
John M Maris, Yael P Mosse, Jonathan P Bradfield, et al.
Nature
|
November 13, 2015
Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
Derek A Oldridge, Andrew C Wood, Nina Weichert-Leahey, et al.
Journal of Translational Medicine
|
February 13, 2024
From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models
Mario Capasso, Chiara Brignole, Vito A Lasorsa, et al.
Viruses
|
June 24, 2022
Carriers of <i>ADAMTS13</i> Rare Variants Are at High Risk of Life-Threatening COVID-19
Kristina Zguro, Margherita Baldassarri, Francesca Fava, et al.
Page
of 17